Logo

Twist Bioscience Corporation

TWST

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital d… read more

Healthcare

Diagnostics & Research

7 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$48.32

Price

-8.74%

-$4.63

Market Cap

$3.009b

Mid

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financial Reports

Key metrics over the past few years and other important metrics. Amounts in USD.

-35.8%

EBITDA Margin

-39.8%

Net Profit Margin

-23.1%

Free Cash Flow Margin

-35.8%

EBITDA Margin

-39.8%

Net Profit Margin

-23.1%

Free Cash Flow Margin
Revenue

$409.479m

+8.7%

1y CAGR

+18.9%

3y CAGR

+19.3%

5y CAGR
Earnings

-$81.276m

-4.6%

1y CAGR

+18.7%

3y CAGR

+15.6%

5y CAGR
EPS

-$1.33

-2.3%

1y CAGR

+20.5%

3y CAGR

+18.1%

5y CAGR
Book Value

$455.094m

$676.214m

Assets

$221.120m

Liabilities

$95.841m

Debt
Debt to Assets

14.2%

-1.6x

Debt to EBITDA
Free Cash Flow

-$95.140m

-25.8%

1y CAGR

+8.1%

3y CAGR

+12.3%

5y CAGR
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases